Vista Private Wealth Partners. LLC Immunome Inc. Call Options Transaction History
Vista Private Wealth Partners. LLC
- $223 Million
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IMNM
# of Institutions
106Shares Held
32.1MCall Options Held
46.1KPut Options Held
32.5K-
Redmile Group, LLC San Francisco, CA4.89MShares$58.8 Million4.76% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$46.7 Million2.73% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.25MShares$27 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.02MShares$24.3 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.64MShares$19.8 Million0.1% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $146M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...